Saeki T - Search Results

1

Safety and feasibility of adjuvant chemotherapy with S-1 in Japanese breast cancer patients after primary systemic chemotherapy: a feasibility study.

Shigekawa T, Osaki A, Sekine H, Sato N, Kanbayashi C, Sano H, Takeuchi H, Ueda S, Nakamiya N, Sugitani I, Sugiyama M, Shimada H, Hirokawa E, Takahashi T, Saeki T. Shigekawa T, et al. Among authors: saeki t. BMC Cancer. 2015 Apr 10;15:253. doi: 10.1186/s12885-015-1289-7. BMC Cancer. 2015. PMID: 25884795 Free PMC article.

2

[Cancer chemotherapy based on evidence--metastatic breast cancer].

Takashima S, Saeki T, Ohsumi S. Takashima S, et al. Among authors: saeki t. Gan To Kagaku Ryoho. 2000 Jan;27(1):44-51. Gan To Kagaku Ryoho. 2000. PMID: 10660732 Review. Japanese.

3

[Combination chemotherapy with vinorelbine and other cytotoxic agents for advanced breast cancer patients--a protocol of vinorelbine plus AC regimens used by the Japan Vinorelbin Study Group].

Saeki T, Adachi I, Ogita M, Tabei T, Shin E, Tamura K, Takashima S. Saeki T, et al. Gan To Kagaku Ryoho. 2000 Jul;27(8):1180-4. Gan To Kagaku Ryoho. 2000. PMID: 10945014 Clinical Trial. Japanese.

4

[Late phase II study of exemestane in postmenopausal patients with breast cancer resistant to anti-estrogenic agents].

Watanabe T, Sano M, Toi M, Saeki T, Kanda K, Miura S, Inaji H, Sono H, Saeki H, Nishimura R, Fujita Y. Watanabe T, et al. Among authors: saeki h, saeki t. Gan To Kagaku Ryoho. 2002 Jul;29(7):1211-21. Gan To Kagaku Ryoho. 2002. PMID: 12146002 Clinical Trial. Japanese.

5

What is the Japanese consensus on adjuvant chemotherapy in breast cancer?

Saeki T. Saeki T. Breast Cancer. 2003;10(1):15-20. doi: 10.1007/BF02967620. Breast Cancer. 2003. PMID: 12525758 Review.

6

[A late phase II clinical study of S-1 in patients with progressed, refractory breast cancer].

Saeki T, Takashima S, Sano M, Horikoshi N, Miura S, Shimizu S, Morimoto K, Kimura M, Taguchi T. Saeki T, et al. Gan To Kagaku Ryoho. 2004 Apr;31(4):539-47. Gan To Kagaku Ryoho. 2004. PMID: 15114697 Clinical Trial. Japanese.

7

Capecitabine plus docetaxel combination chemotherapy for metastatic breast cancer.

Saeki T, Takashima S. Saeki T, et al. Breast Cancer. 2004;11(2):116-20. doi: 10.1007/BF02968289. Breast Cancer. 2004. PMID: 15550855 Review.

8

[Recent perspectives second-line chemotherapy for breast cancer].

Fujiuchi N, Ohokubo K, Saeki T, Sasaki Y. Fujiuchi N, et al. Among authors: saeki t. Gan To Kagaku Ryoho. 2005 Jan;32(1):11-4. Gan To Kagaku Ryoho. 2005. PMID: 15675574 Review. Japanese.

9

A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors.

Saeki T, Takashima S, Terashima M, Satoh A, Toi M, Osaki A, Toge T, Ohno S, Nomura N, Fukuyama Y, Koizumi W, Taguchi T. Saeki T, et al. Int J Clin Oncol. 2005 Feb;10(1):51-7. doi: 10.1007/s10147-004-0460-y. Int J Clin Oncol. 2005. PMID: 15729602 Clinical Trial.

10

[Toxicity of doxorubicin and cyclophosphamide (60 mg/600 mg/m2) in adjuvant chemotherapy for breast cancer].

Tsutani Y, Saeki T, Aogi K, Ohsumi S, Takashima S. Tsutani Y, et al. Among authors: saeki t. Gan To Kagaku Ryoho. 2005 Jun;32(6):809-13. Gan To Kagaku Ryoho. 2005. PMID: 15984521 Clinical Trial. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

746 results

Search Page